Skip to main content
. 2021 Jun 3;13(6):1919. doi: 10.3390/nu13061919

Table 2.

Biochemical and clinical characterization of individuals.

Variables n Total
SBP (mmHg) 356 133 (18.0)
DBP (mmHg)
Hypertension (≥140 mmHg) (n, %)
356 81 (10.0)
111 (31.2)
BMI (kg/m2)
Obesity (BMI ≥ 30.0 kg/m2) (n, %)
356 30.9 (5.8)
182 (51.1)
Total cholesterol (mg/dL)
Hypercholesterolemia (≥200mg/dL) (n, %)
354 205.0 (42.6)
193 (54.2)
LDL-c (mg/dL)
High LDL-c (≥130 mg/dL) (n, %)
340 137.3 (38.7)
196 (55.1)
HDL-c (mg/dL)
Low-HDL-c (<40 mg/dL) (n, %)
354 36.0 (30.0–42.3)
125 (35.1)
Triglycerides (mg/dL)
Hypertriglyceridemia (≥150 mg/dL) (n, %)
354 130.5 (98.0–191.3)
145 (40.7)
Glucose (mg/dL)
Hyperglycemia (≥100 mg/dL) (n, %)
354 98.0 (91.0–108.0)
164 (46.1)
Apo A-I (mg/dL)
Low-Apo A-I (<120 mg/dL) (n, %)
355 132.2 (25.7)
230 (64.6)
Apo B (mg/dL)
High-Apo B (≥120 mg/dL) (n, %)
355 104.7 (24.8)
88 (24.7)
C-reactive protein (mg/L)
High-CRP (>1.0 mg/L) (n, %)
347 2.84 (1.2–6.0)
275 (77.2)

Categorical variables are shown as absolute value (n) and frequency (%). Continuous variables are shown as mean (standard deviation) or median (interquartile range). BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; TG: triglycerides; LDL-c: low density lipoprotein-cholesterol, HDL-c: high density lipoprotein-cholesterol.